A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis.
Polman, Chris H.; O'Connor, Paul W.; Havrdova, Eva; Hutchinson, Michael; Kappos, Ludwig; Miller, David H.; Phillips, J. Theodore; Lublin, Fred D.; Giovannoni, Gavin; Wajgt, Andrzej; Toal, Martin; Lynn, Frances; Panzara, Michael A.; Sandrock, Alfred W.; New England Journal of Medicine, 2006, vol. 354, issue 9, p 899, ISSN 00284793. ISBN 00284793.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef